SEC Form 4 · accession 0001127602-19-008342
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 25, 2019
Accepted (ET)
Feb 26, 2019 · 3:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2019 | S | 111 | $145.60 | D | 290,609 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.61 | D | 290,409 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.615 | D | 290,209 | D | |
| Common Stock | Feb 25, 2019 | S | 75 | $145.64 | D | 290,134 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.65 | D | 289,934 | D | |
| Common Stock | Feb 25, 2019 | S | 1 | $145.66 | D | 289,933 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $145.67 | D | 289,533 | D | |
| Common Stock | Feb 25, 2019 | S | 44 | $145.70 | D | 289,489 | D | |
| Common Stock | Feb 25, 2019 | S | 40 | $145.705 | D | 289,449 | D | |
| Common Stock | Feb 25, 2019 | S | 5 | $145.71 | D | 289,444 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $145.72 | D | 289,144 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.73 | D | 289,044 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.74 | D | 288,844 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.76 | D | 288,744 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.82 | D | 288,544 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.83 | D | 288,344 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.84 | D | 288,244 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $145.86 | D | 287,844 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.88 | D | 287,744 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $145.90 | D | 287,444 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.91 | D | 287,344 | D | |
| Common Stock | Feb 25, 2019 | S | 600 | $145.93 | D | 286,744 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.95 | D | 286,644 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.